Munc13-4 is a member of the UNC13 family, containing similar domain structure as other family members but lacking an N-terminalphorbol ester-binding C1 domain present in other Munc13 proteins. The protein appears to play a role in vesicle maturation during exocytosis and is involved in regulation of cytolytic granules secretion.
Munc13-4 is an essential protein in the intracellular trafficking and exocytosis of lytic granules. It is targeted to CD63 positive secretory lysosomes. The C-terminal C2 domain of the protein is involved in this process.[2]
↑Elstak ED, Te Loo M, Tesselaar K, van Kerkhof P, Loeffen J, Grivas D, Hennekam E, Boelens JJ, Hoogerbrugge PM, van der Sluijs P, van Gijn ME, van de Corput L (July 2011). "A novel Dutch mutation in UNC13D reveals an essential role of the C2B domain in munc13-4 function". Pediatr Blood Cancer. 58 (4): 598–605. doi:10.1002/pbc.23253. PMID21755595.
Further reading
Marcenaro S, Gallo F, Martini S, et al. (2006). "Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease". Blood. 108 (7): 2316–23. doi:10.1182/blood-2006-04-015693. PMID16778144.
Gurgey A, Unal S, Okur H, et al. (2008). "Neonatal primary hemophagocytic lymphohistiocytosis in Turkish children". J. Pediatr. Hematol. Oncol. 30 (12): 871–6. doi:10.1097/MPH.0b013e31818a9577. PMID19131769.
Saxena SK, Horiuchi H, Fukuda M (2006). "Rab27a regulates epithelial sodium channel (ENaC) activity through synaptotagmin-like protein (SLP-5) and Munc13-4 effector mechanism". Biochem. Biophys. Res. Commun. 344 (2): 651–7. doi:10.1016/j.bbrc.2006.03.160. PMID16630545.
Ménager MM, Ménasché G, Romao M, et al. (2007). "Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4". Nat. Immunol. 8 (3): 257–67. doi:10.1038/ni1431. PMID17237785.
Santoro A, Cannella S, Trizzino A, et al. (2008). "Mutations affecting mRNA splicing are the most common molecular defect in patients with familial hemophagocytic lymphohistiocytosis type 3". Haematologica. 93 (7): 1086–90. doi:10.3324/haematol.12622. PMID18492689.
Horne A, Ramme KG, Rudd E, et al. (2008). "Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis". Br. J. Haematol. 143 (1): 75–83. doi:10.1111/j.1365-2141.2008.07315.x. PMID18710388.
Zur Stadt U, Beutel K, Kolberg S, et al. (2006). "Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A". Hum. Mutat. 27 (1): 62–8. doi:10.1002/humu.20274. PMID16278825.
Rudd E, Bryceson YT, Zheng C, et al. (2008). "Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis". J. Med. Genet. 45 (3): 134–41. doi:10.1136/jmg.2007.054288. PMID17993578.
Hazen MM, Woodward AL, Hofmann I, et al. (2008). "Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis". Arthritis Rheum. 58 (2): 567–70. doi:10.1002/art.23199. PMID18240215.
Pivot-Pajot C, Varoqueaux F, de Saint Basile G, Bourgoin SG (2008). "Munc13-4 regulates granule secretion in human neutrophils". J. Immunol. 180 (10): 6786–97. doi:10.4049/jimmunol.180.10.6786. PMID18453599.
Wood SM, Meeths M, Chiang SC, et al. (2009). "Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity". Blood. 114 (19): 4117–27. doi:10.1182/blood-2009-06-225359. PMID19704116.
Zhong N, Radu G, Ju W, Brown WT (2005). "Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/C". Biochem. Biophys. Res. Commun. 338 (2): 855–61. doi:10.1016/j.bbrc.2005.10.020. PMID16248985.